Karnataka: Shivamogga Doctor Dies; Govt Says Not Linked To Vaccine

BENGALURU : A 58-year-old doctor from Shivamogga died on Wednesday, two days after he was given Covishield vaccine. The Union health ministry’s report on Adverse Effects Following Immunisation said the death was due to cardiac problems. District health officer Rajesh Suragihalli said the death of Dr Jayaprakash TA, who was with Subbaiah medical college hospital, is not linked to the vaccination drive.

He developed severe chest pain in the early hours of Wednesday and was admitted to a private hospital where he died hours later, said Dr SM Katti, principal of the medical college. District health officer Dr Rajesh Suragihalli told TOI: “He died due to cardiac problems. He had been suffering from heart-related issues for some time now. His death is not related to the vaccine drive, which is also confirmed by the Union health ministry. After taking vaccination, he had shared his pictures on social media and requested frontline warriors to come forward.”

Jayaprakash’s wife, a gynaecologist who works in Shivamogga, and two daughters are away in the US. Katti said the doctor suffered a cardiac arrest and the death is not linked to the vaccine.

Pankaj Kumar Pandey, commissioner, health and family welfare department, said the doctor had conducted classes after his vaccination and was doing well after taking the jab. “It is learned that he was highly diabetic and had undergone bypass surgery earlier. The reports say that he has died due to cardiac arrest,” he said.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid